Xatral and Xatral XL 10mg (alfuzosin) - Revised SPC

Source: eMC (electronic Medicines Compendium)

Date published: 02/06/2011 10:38

Type of SPC Change: Revised SPC

Generic drug name: Alfuzosin

Drug brand name: Xatral

Legal status: POM

Pharmaceutical manufacturer: Sanofi Aventis

Summary
by: Shenal Shah

Section 4.2 of the SPCs for Xatral XL and Xatral have been updated to include that the efficacy of alfuzosin has not been demonstrated in children aged 2 to 16 years, and it is therefore not indicated for use in the paediatric population.

Please see below for link to SPCs and full prescribing information.l

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.